Bernd Metzner
Klinikum Oldenburg(DE)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research, Viral-associated cancers and disorders, Testicular diseases and treatments
Most-Cited Works
- → Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)(2008)1,130 cited
- → A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma(2007)963 cited
- → Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group(2010)589 cited
- → Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)(2005)573 cited
- → Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG)(2006)464 cited